Eli lilly stock has reached a new record high, with some outlets suggesting this is due to its deal with trump, while others point to factors such as cvs coverage for its product zepbound. The company's valuation has reportedly surpassed a significant milestone, although the exact details are unclear. The stock's surge is part of a broader market trend, with other major indexes and companies also reaching record highs.